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Achieve Zen  
(and Hair)
Alopecia areata (AA) is 
an inflammatory hair loss 
disease with an autoimmune 
component. Environmental 
factors such as stress contribute 
to this disease, possibly 
through modulation of the 
hypothalamic–pituitary–adrenal 
(HPA) axis via activation of the 
immune system. In investigating 
the relationship between stress 
and AA in a mouse model, 
Zhang and colleagues found a 
blunted systemic HPA response 
to acute physiological stress 
and defective adaptation to 
repeated psychological stress. 
These mice also exhibited 
highly active central and 
peripheral HPA activity. 
These data support stress 
management as an adjunctive 
clinical treatment for AA.  
See page 1527
Unfavorable EBV
Antigenic stimulation via 
persistent infectious agents 
has been implicated in the 
etiopathogenesis of primary 
cutaneous T-cell lymphomas 
(CTCLs). In response to 
conflicting reports of the 
incidence of Epstein–Barr virus 
(EBV) in CTCL patients, Novelli 
and colleagues identified EBV 
DNA in 27% of individuals with 
Sézary syndrome and 10% of 
mycosis fungoides patients, 
whereas all healthy control 
patients were negative for the 
virus. The presence of EBV DNA 
correlated with lower survival 
in both CTCL patient subsets. 
Thus, EBV monitoring in CTCL 
patients is warranted because 
viral presence is an additional 
unfavorable prognostic factor. 
See page 1556
Hotspots or Not
Differentiation-dependent epidermal expres-
sion of lipoxygenases (LOX) suggests a role for 
these proteins in the regulation of keratinocyte 
proliferation and differentiation. Mutations in 
the genes encoding 12R-LOX and eLOX-3 have 
been implicated in autosomal recessive con-
genital ichthyosis (ARCI), a heterogeneous group 
of severe keratinization disorders. Eckl and col-
leagues identified 11 novel inactivating muta-
tions in these genes in patients who spanned the 
ARCI phenotypic spectrum. Interestingly, two 
mutational hotspots were identified in eLOX-3, 
whereas 12R-LOX exhibited allelic heterogeneity. These findings not only illumi-
nate potential diagnostic strategies for ARCI but also confirm the importance of the 
12-lipoxygenase pathway in epidermal differentiation. See page 1421
Mutational Journey
A succession of genetic alterations underlies can-
cer progression. In melanoma, cancer progress-
es from precursor melanoma to a radial growth 
phase (RGP) to a vertical growth phase (VGP) 
tumor. Greene and colleagues demonstrated an 
incremental increase in mutation rates in NRAS 
and BRAF with the progression from RGP to 
VGP. Moreover, quantitative analysis of muta-
tion occurrence in these two phases revealed 
an increase in the percentage of mutated DNA 
in the VGP compared with the RGP portion in 
tumors containing mutations in both phases. 
Together, these findings support the notion that NRAS and BRAF mutations increase 
with progression of melanoma. See page 1483
Calcium Strata
Mutations in genes involved in calcium seques-
tration in the Golgi and endoplasmic reticulum 
have been implicated in Hailey–Hailey disease 
(HHD) and Darier disease (DD), which are 
characterized by acantholysis at the epidermal 
suprabasal layer. Using electron probe micro-
analysis, Leinonen and colleagues discovered a 
calcium decrease from the stratum corneum to 
the spinous layer and an unexpected calcium 
increase in the basal cell layer of normal epider-
mis. Low calcium content in the basal cell layer 
appears to underlie the pathogenesis of HHD 
lesions but not necessarily that of DD lesions. In addition, purigenic ATP-mediated 
calcium signaling was also altered in HHD and DD epidermis, supporting the pres-
ence of a defective epidermal calcium gradient. See page 1379
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